# Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

> **NCT01156051** · PHASE4 · TERMINATED · sponsor: **Children's Specialized Hospital** · enrollment: 29 (actual)

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder
- Attention Deficit Disorder
- Insomnia
- Sleep Disorders

## Interventions

- **DRUG:** Guanfacine extended-release tablets
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT01156051
- **Lead sponsor:** Children's Specialized Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** extended beyond completion date; chose to close out rather than renew IRB review
- **Last updated:** 2014-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01156051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01156051, "Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01156051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*